ORIGINAL RESEARCH ARTICLES |



* Department of Infectious Disease, University of Pittsburgh Medical Center, Pittsburgh, PA;
Department of Pathology;
Department of Infectious Disease, University of California Los Angeles, Los Angeles, CA, USA
Correspondence to: Dr Ross D Cranston, University of Pittsburgh Medical Center, Falk Medical Building, Suite 611, 3601 Fifth Avenue, Pittsburgh PA 15213, USA Email: cranstonr{at}dom.pitt.edu
HIV-positive men who have sex with men (MSM) are at high risk of developing human papillomavirus-associated anal squamous cell cancer. Similar to the management of cervical dysplasia, clinicians are treating high-grade anal dysplasia to prevent progression to cancer. Initial treatments such as cold scalpel excision and electrofulguration have shown limited efficacy in a HIV-positive population. Infrared coagulation (IRC) is an outpatient treatment for high-grade anal dysplasia. This retrospective clinical study reports on 68 HIV-positive MSM with 78 biopsy proven high-grade anal lesions. Each lesion was treated with the IRC with re-biopsy of the treatment site a mean of 140 days later. Of the 74 evaluable lesions; 39 had anal intraepithelial neoplasia (AIN) 1, 20 had AIN 2, seven had AIN 3, and eight had normal epithelium. The IRC showed 64% efficacy per treated lesion and shows promise as a treatment modality for high-grade anal dysplasia in this population.
Key Words: anal dysplasia infrared coagulation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M B O'Connor and C O'Connor The HPV vaccine for men Int J STD AIDS, April 1, 2009; 20(4): 290 - 291. [Full Text] [PDF] |
||||
![]() |
R. D Cranston Anal cancer prevention: how we are failing men who have sex with men Sex Transm Inf, November 1, 2008; 84(6): 417 - 419. [Full Text] [PDF] |
||||